PLASMA therapy is a safe, effective and reliable treatment providing patients with a number of benefits:
EAU = European Association of Urology (an international community of over 16,000 medical professionals sharing best practice and the latest knowledge in urological research and care http://www.uroweb.org)
IPSS = International Prostate Symptom Score measures the severy of BPH symptoms based on 8 questions
TUR syndrome = A severe complication, which can lead e.g. to cardiovascular problems or renal failure
Safe: Increased patient safety
When doctors talk about PLASMA therapy, often the first thing they mention is the increased safety profile of PLASMA compared to monopolar therapy. Translated into non-medical language, this means that there will be less thermal damage and bleeding during the TURP procedure and thus less pain, discomfort and infection after the operation. This will also reduce your time in hospital compared to monopolar therapy. Additionally, with PLASMA therapy there is no risk of transurethral resection (TUR) syndrome. Due to reduced side effects the recovery time is faster.
Effective: long-term symptomatic relief
If your doctor has recommended surgery, your International Prostate Symptom Score (IPSS) was most likely in the moderate-to-severe area. This will most likely dramatically change after PLASMA therapy. Statistically, within the first year after PLASMA treatment, the IPSS will fall permanently to around 5. The treatment not only provides long-lasting results but also allows you to discontinue your medication after the surgery.
Reliable: most widespread and thoroughly proven treatment
More than 3.1 million PLASMA prostate procedures have been performed worldwide over the last ten years. This is one reason why the European Association of Urology (EAU) describes PLASMA therapy in its current guidelines as among the most frequently recommended first-choice treatment for all prostate sizes. The EAU is the leading authority within Europe, and fosters standards of urological care and practice.
Symptoms are reduced as effectively and permanently as with the present standard procedure but with a more favourable perioperative profile.